# FDA Inspection 1102647 - CMAX Clinical Research Pty Ltd - August 16, 2019

Source: https://www.keypedia.com/records/fda_inspections/cmax-clinical-research-pty-ltd/5df64f05-913a-480e-a439-262c5f672922
Source feed: FDA_Inspections

> FDA Inspection 1102647 for CMAX Clinical Research Pty Ltd on August 16, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1102647
- Company Name: CMAX Clinical Research Pty Ltd
- Inspection Date: 2019-08-16
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1226812 - 2023-11-10](https://www.keypedia.com/records/fda_inspections/cmax-clinical-research-pty-ltd/1a680925-23eb-43f7-8496-ac875aecb474)

Company: https://www.keypedia.com/companies/cmax-clinical-research-pty-ltd/26755e14-41c1-4885-be4a-f44e7e956ce6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c